top of page

Frontiers Topic Open for Submissions - Enzymes in Brain Trauma and Disease

Frontiers is the 3rd most-cited research publisher and reports groundbreaking discoveries by the world's top experts. Frontiers, Experimental Therapeutics is now accepting submissions that highlight the roles of enzymes in neurological injury or disease. Authors are also encouraged to submit relevant work describing enzymes associated with infectious agents, e.g. SARS-CoV-2, as applicable to neurological symptoms and / or damage.

Visit Frontiers to learn more

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

22 views0 comments

Recent Posts

See All

Are you interested in #biomarkers and #therapeutics for #neurologicaldisease and #brainhealth? Aries Biotech want to hear from you! Your perspective holds immense value for us and we recognize the vit

Aries Biotech extends gratitude to CSIRO, Australia's national science agency, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to discuss health initiatives. At Aries Biotech, we believ

Revolutionizing Neuroscience and Neurotrauma: Aries Biotech Announces New Services Available to KOLs and Investors Aries Biotechnologies is thrilled to introduce

bottom of page